NIVF
NewGenIvfNIVF
NIVF
0
Funds holding %
of 7,398 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
0.15% more ownership
Funds ownership: 1.36% [Q3] → 1.52% (+0.15%) [Q4]
0% more funds holding
Funds holding: 7 [Q3] → 7 (+0) [Q4]
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
35% less capital invested
Capital invested by funds: $94.3K [Q3] → $61.3K (-$32.9K) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for NIVF.
Financial journalist opinion
Based on 4 articles about NIVF published over the past 30 days
Negative
Benzinga
1 day ago
Dow Gains Over 100 Points; NewGenIvf Group Shares Plummet
U.S. stocks traded mixed midway through trading, with the Dow Jones gaining more than 100 points on Monday.
Neutral
GlobeNewsWire
1 day ago
NewGenIVF Announces Termination of Proposed Reverse Merger Transaction with European Wellness
BANGKOK, March 31, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has terminated the binding term sheet with healthcare company European Wellness Investment Holdings Limited (“EWIHL”) regarding their previously announced reverse merger transaction.
Neutral
GlobeNewsWire
3 weeks ago
NewGenIvf Provides Update on Proposed Reverse Merger with European Wellness Holdings and Completion of Strategic Acquisition of MicroSort Reproductive Technology
BANGKOK, March 08, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced an update on its proposed reverse merger with healthcare company European Wellness Investment Holdings Limited (“EWIHL”) and its completion of its acquisition of MicroSort Reproductive Technology.
Neutral
GlobeNewsWire
4 weeks ago
NewGen and BOBCARE Announce Strategic Collaboration to Expand Fertility Services in Kyrgyzstan
BANGKOK, March 03, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, announced that it has entered into a strategic collaboration agreement with BOBCARE FERTILITY GROUP LLC (“BOBCARE”) to jointly develop fertility services in the Kyrgyzstan market.
Neutral
GlobeNewsWire
1 month ago
NewGen Regains Compliance with Nasdaq Minimum Bid Price Requirement and Announces Listing Transfer to the Nasdaq Capital Market
BANGKOK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has received a written notice (the “Compliance Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) dated February 27, 2025, informing the Company that it has regained compliance with the minimum bid price requirement set forth under the Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”).
Neutral
GlobeNewsWire
1 month ago
NewGen Issues Clarification on Press Release Titled “NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director” dated February 20, 2025
BANGKOK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”) today issued a clarification that, in the press release titled “NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director” issued on February 20, 2025, the Company did not intend to imply that it has already achieved compliance with the Nasdaq Capital Market's $2.5 million minimum stockholders' equity requirement (the “Equity Rule”). However, during its 1st quarter to date, certain NewGen debtholders converted $2.3 million of debt to equity and the Company has drawn down approximately $4.3 million from its Equity Line of Credit with White Lion Capital. Therefore, the Company believes it has in excess of $2.5 million in stockholders' equity as of this date. The Company is awaiting confirmation from Nasdaq that it has evidenced compliance with the Equity Rule. However, there can be no assurance that Nasdaq will determine that the Company has regained compliance with the Nasdaq continued listing rules.
Neutral
GlobeNewsWire
1 month ago
NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director
Company Granted Request to Continue its Listing on Nasdaq Appoints Thorain Ko to Lead Business Development Initiatives
Neutral
GlobeNewsWire
1 month ago
NewGen Announces Reverse Stock Split
NewGen's ordinary shares to begin trading on a split-adjusted basis on February 11, 2025 NewGen's ordinary shares to begin trading on a split-adjusted basis on February 11, 2025
Neutral
GlobeNewsWire
2 months ago
NewGen Announces Strategic Acquisition of MicroSort Reproductive Technology
The technology, which will be acquired for US$5 million, allows for t he separation of X and Y chromosome-bearing sperm cells
Neutral
GlobeNewsWire
2 months ago
NewGen Launches Innovative Lifetime Egg Freezing Service to Address Growing Market Need in Asia
New service will address a significant market opportunity and grant new flexibility to women seeking reproductive flexibility New service will address a significant market opportunity and grant new flexibility to women seeking reproductive flexibility
Charts implemented using Lightweight Charts™